Adverse events80

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 80

Type	Event	Organ system	Group	Affected	At risk
other	Bronchitis	Infections and infestations	TA-650	0	16
other	Bronchitis	Infections and infestations	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	2	15
other	Conjunctivitis	Infections and infestations	TA-650	0	16
other	Conjunctivitis	Infections and infestations	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	1	15
other	Fungal skin infection	Infections and infestations	TA-650	0	16
other	Fungal skin infection	Infections and infestations	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	1	15
other	Nasopharyngitis	Infections and infestations	TA-650	3	16
other	Nasopharyngitis	Infections and infestations	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	2	15
other	Pharyngitis	Infections and infestations	TA-650	0	16
other	Pharyngitis	Infections and infestations	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	1	15
other	Upper respiratory tract infection	Infections and infestations	TA-650	1	16
other	Upper respiratory tract infection	Infections and infestations	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	2	15
other	Neuralgia	Nervous system disorders	TA-650	1	16
other	Neuralgia	Nervous system disorders	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	0	15
other	Ear pain	Ear and labyrinth disorders	TA-650	1	16
other	Ear pain	Ear and labyrinth disorders	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	0	15
other	Epistaxis	Respiratory, thoracic and mediastinal disorders	TA-650	3	16
other	Epistaxis	Respiratory, thoracic and mediastinal disorders	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	4	15
other	Respiratory depression	Respiratory, thoracic and mediastinal disorders	TA-650	0	16
other	Respiratory depression	Respiratory, thoracic and mediastinal disorders	Polyethylene Glycol-treated Human Immunoglobulin (VGIH)	1	15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01596335/events

API reference For AI assistants

Adverse events80

Sources 3

Read this list from software.